Yeon Kim | Medicine and Health Sciences | Best Researcher Award

Published on 04/10/202504/10/2025 by Research Hypothesis

Dr. Yeon Kim | Medicine and Health Sciences | Best Researcher Award

Professor | California State University San Bernardino | United States

Dr. Yeon Kim is a distinguished nursing scholar whose career weaves together rigorous education, extensive professional experience, and a strong trajectory in research and mentorship. She earned her Doctor of Nursing Practice degree from California State University through the DNP Consortium Program, following a Master of Science in Nursing from California State University, Dominguez Hills, and a Bachelor of Science in Nursing from Seoul National University. In her academic career, Dr. Yeon Kim has served as professor and associate professor in the Department of Nursing at California State University, San Bernardino, and previously held assistant professor roles, adjunct faculty appointments, and clinical teaching positions across several institutions. Her professional experience extends beyond academia into the clinical domain—she practiced in intensive care units, telemetry floors, and emergency departments, and held leadership roles like Alternate Lead Nurse in Burn Intensive Care Units. Her research interests center on nursing leadership and management, health disparities among minority populations, digital healthcare innovation in education, incivility and professionalism in nursing students, and curriculum development to enhance clinical competence. Dr. Yeon Kim is adept in a variety of research skills including quantitative and qualitative methodologies, survey design, statistical analysis (using SPSS, R), mixed-methods integration, grant writing, program evaluation, and interprofessional collaboration. Over the course of her scholarly work she has authored 11 documents, accrued 82 citations, and holds an h-index of 4. Her honors and awards include multiple internal grant awards from California State University (such as the Professors Across Borders Grant, Teaching Skills Study Award, Faculty Learning Community funding), external funding through the Department of Health Care Access and Information, recognition for instructional excellence, and leadership in curriculum development and faculty mentoring. In conclusion, Dr. Yeon Kim represents a consummate scholar-practitioner whose blend of educational depth, clinical insight, administrative acumen, and scholarly productivity position her as a leader in nursing education and research. Her sustained commitment to improving nursing pedagogy, bridging theory and practice, fostering student engagement, and expanding research on equity and digital health demonstrates that she is well poised to make lasting contributions to both the academic community and global healthcare outcomes.

Profile: Google scholar | Scopus

Featured Publications

Kim, Y. (2022). Leadership styles and nurse retention: A meta-analysis. Journal of Nursing Management, (cited 25)
Kim, Y. (2021). Digital simulation in undergraduate nursing education: Effects on clinical reasoning. Nurse Education Today, (cited 18)
Kim, Y. (2020). Incivility among nursing students: Prevalence and coping strategies. International Journal of Nursing Studies, (cited 12)
Kim, Y. (2019). Evaluating a curriculum intervention to improve clinical judgment in junior nurses. Nurse Educator, (cited 15)
Kim, Y. (2018). Disparities in health outcomes among Korean American older adults: A comparative study. Journal of Transcultural Nursing, (cited 8)
Kim, Y. (2017). Technology acceptance and e-learning readiness among nursing faculty. Computers, Informatics, Nursing, (cited 4)

Jian Liu | Medicine and Health Sciences | Best Researcher Award

Published on 08/08/202508/08/2025 by Research Hypothesis

Prof. Jian Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Jian Liu | Medicine and Health Sciences | Director of Anesthesiology Department | Tongji Hospital in Tongji University | China

Prof. Liu Jianhui is the Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, serving as a Professor, Chief Physician, and PhD Supervisor, as well as an Excellent Academic Leader of the Shanghai Municipal Health Commission and a Shanghai Pujiang Talent. She specializes in perioperative neuroimmunology, leading a research team focused on uncovering the mechanisms and developing intervention strategies for perioperative cognitive dysfunction. She has successfully led multiple high-profile research projects, including several funded by the National Natural Science Foundation of China, and has published influential studies in leading journals such as Journal of Neuroinflammation, Anesthesia & Analgesia, Brain, Behavior and Immunity, and British Journal of Anaesthesia. In addition to her research achievements, she serves on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holds key positions in several national professional committees, reflecting her leadership, academic influence, and dedication to advancing anesthesiology and perioperative medicine.

Professional Profile

Scopus Profile

Education

Prof. Liu Jianhui has pursued an extensive academic path in medicine, specializing in anesthesiology and perioperative medicine, with advanced training that integrates both clinical expertise and research proficiency. She has earned her medical degree followed by postgraduate and doctoral studies, focusing on the intricate mechanisms of perioperative neuroimmunology. Her academic journey has been complemented by specialized training in clinical anesthesia, translational medicine, and neurocognitive function, equipping her with a strong foundation to bridge basic research and clinical application. This comprehensive educational background has enabled her to lead cutting-edge research, mentor doctoral candidates, and contribute significantly to the advancement of anesthesiology at both national and international levels.

Professional Experience

Prof. Liu Jianhui has built a distinguished professional career as Director of the Department of Anesthesiology at Tongji Hospital, Tongji University, where she also serves as Professor, Chief Physician, and PhD Supervisor. She has led numerous research initiatives in perioperative neuroimmunology, with a focus on understanding and addressing perioperative cognitive dysfunction. Her leadership extends beyond the hospital, serving on the editorial boards of Medical Gas Research and Anesthesia and Perioperative Science, and holding prominent roles in national professional societies, including the Standing Committee of the Society of Perioperative Basic and Translational Medicine of the Chinese Society of Anesthesiology, the Society of Innovation and Promotion of Cardiothoracic Anesthesia, and the Society of Anesthesia and Brain Function. Through her clinical expertise, academic leadership, and active participation in professional organizations, she has made significant contributions to advancing anesthesiology and perioperative medicine.

Research Interest

Prof. Liu Jianhui’s research interests center on perioperative neuroimmunology, with a particular focus on the mechanisms and intervention strategies for perioperative cognitive dysfunction. She is dedicated to exploring how surgical and anesthetic factors influence neuroimmune pathways and cognitive outcomes, aiming to identify preventive and therapeutic approaches that can improve patient recovery and quality of life. Her work bridges basic science and clinical practice, integrating molecular, cellular, and systemic perspectives to uncover novel targets for intervention. By combining translational research with clinical application, she strives to advance the understanding of brain function in the perioperative period and contribute to the development of evidence-based strategies that enhance patient care in anesthesiology.

Award and Honor

Prof. Liu Jianhui has been recognized with numerous prestigious awards and honors that reflect her exceptional contributions to anesthesiology and medical research. She has been named an Excellent Academic Leader by the Shanghai Municipal Health Commission and honored as a Shanghai Pujiang Talent, acknowledging her leadership, innovation, and impact in her field. Her achievements in advancing perioperative neuroimmunology and cognitive dysfunction research have earned her national recognition, while her influential publications and service on editorial boards highlight her standing in the international academic community. These distinctions underscore her commitment to excellence, her role as a thought leader, and her significant influence on both clinical practice and scientific advancement.

Publications Top Noted

Preoperative tyrosine is associated with postoperative delayed neurocognitive recovery in elderly: Evidence from two hospitals | Year : 2025

Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation | Year : 2025

The Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production | Year : 2025

Conclusion

Prof. Liu Jianhui’s pioneering research, leadership in anesthesiology, and significant contributions to perioperative neuroimmunology make her a highly deserving candidate for the Best Researcher Award. Her scientific excellence, clinical impact, and commitment to advancing the medical community strongly align with the award’s vision of recognizing transformative contributions to research and healthcare innovation.

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Published on 13/03/202513/03/2025 by Research Hypothesis

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year 🏆 (Miller School of Medicine, 2015), the Outstanding Care Award 🏅 (Sarcoma Alliance, 2012), and the Leadership in Clinical Research 🎖️ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Published on 06/12/202406/12/2024 by Research Hypothesis

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Dr Federico Bozzetti, ASLC, Italy

Dr. Federico Bozzetti is an esteemed Italian physician and specialist in oncology and surgery, born in Milan, Italy. He completed his studies at the University of Milan, University of Florence, and University of Pavia, followed by specialized training at renowned institutions like Lund University and Columbia University. With over 710 publications, including articles on cancer nutrition and home parenteral nutrition, Dr. Bozzetti is a leader in gastrointestinal oncology and artificial nutrition. He has held significant roles in prestigious societies, including as President of ESPEN. His research focuses on cancer treatment, liver transplantation, and cancer-related malnutrition.

Publication Profile

Orcid

Educational Background

Dr. Federico Bozzetti is a distinguished medical professional with multiple specializations in medicine, surgery, oncology, and epidemiology, earned from prestigious institutions such as the University of Milan, University of Pavia, and University of Florence 🎓🏥. Known for his academic excellence, he graduated with cum laude honors and achieved top scores in various examinations 🌟📚. Dr. Bozzetti’s vast expertise in medicine and cancer care has significantly impacted the field, reflecting his dedication to both clinical practice and research 🔬💉. His contributions continue to shape advancements in healthcare, particularly in oncology and epidemiology 🌍💪.

Experience

Dr. Federico Bozzetti is a renowned expert in cancer treatment and nutritional support. He has held leadership roles at prestigious institutions, including the Istituto Nazionale per lo Studio e la Cura dei Tumori in Milan. His groundbreaking research and clinical contributions have greatly advanced cancer care, particularly in the areas of nutrition for cancer patients. With a deep commitment to improving patient outcomes, Dr. Bozzetti’s work continues to inspire and shape the future of oncology and supportive care.

Global Influence

Dr. Bozzetti is a highly influential figure in the field of parenteral and enteral nutrition. His active involvement in numerous professional societies showcases his global impact. He is a founder and key member of both the European and Italian Societies of Parenteral and Enteral Nutrition (ESPEN and ISPEN). In addition to his contributions to these societies, Dr. Bozzetti plays a significant role in international collaborations, further advancing the field. He is also an esteemed member of various editorial boards, enhancing the scientific community with his expertise. 🌍🍽️📚💡🌱

Research Focus

Dr. Federico Bozzetti’s research primarily focuses on clinical nutrition, particularly in the context of cancer patients and those requiring specialized nutrition support. His work explores the role of physical exercise in improving outcomes for advanced cancer patients undergoing systemic therapy, as well as the challenges and outcomes of home enteral nutrition for patients and caregivers. Dr. Bozzetti also revisits the importance of nutrition for malnourished cancer patients, and he contributes to guidelines on home parenteral nutrition. His research seeks to improve patient care through better understanding of nutritional needs and therapy during illness. 🍽️🏥💪📚

Publication top Notes

Potential Benefits from Physical Exercise in Advanced Cancer Patients Undergoing Systemic Therapy? A Narrative Review of the Randomized Clinical Trials

Patients’ and caregivers’ perspective on challenges and outcomes with tube feeding: Analysis of home enteral nutrition survey data

The role of the nutrition in malnourished cancer patients: Revisiting an old dilemma

ESPEN practical guideline: Home parenteral nutrition

How to deal with micronutrient product shortage – Editorial

Cost of HPN in incurable cancer patients: Author’s response re. “SINPE Position Paper on the use of home parenteral nutrition in cancer patients”

A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer

Does nutrition support during chemotherapy increase long-term survival of cancer patients? Lessons from the past and future perspectives

TEMPORARY REMOVAL: SINPE Position Paper on the use of home parenteral nutrition in cancer patients

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Published on 31/07/202431/07/2024 by Research Hypothesis

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Dr Ahmed Ali, Beni-Suef University, Egypt

Based on Dr. Ahmed Ali’s extensive background in veterinary medicine, his significant contributions to vaccine development, and his active research in poultry diseases and vaccine efficacy, he appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

google scholar

Education and Training

Dr. Ali holds advanced degrees in Veterinary Medicine and Poultry Diseases from Beni-Suef University and The Ohio State University, showcasing a solid educational foundation in his field.

Research Contributions

His work includes leading the development of reverse genetics vaccines for avian influenza and Newcastle disease, and his involvement in live attenuated and inactivated vaccine research. This demonstrates a high level of expertise and impact in vaccine research and development.

Professional Experience

Dr. Ali has held various positions, from demonstrator to technical manager, and has been involved in significant roles related to vaccine R&D and quality control at MEVAC and the National Veterinary Vaccine Co. His roles highlight a career dedicated to advancing vaccine technologies and ensuring their quality and safety.

Publications

He has authored numerous research articles on vaccine safety, efficacy, and development, contributing valuable knowledge to the field. His research is published in reputable journals, reflecting the quality and relevance of his work.

Certifications and Skills

Dr. Ali’s certifications in biorisk management, strategic planning, and Six Sigma further demonstrate his commitment to excellence and continuous improvement in his field.

Field Achievements

His leadership in developing innovative vaccines and ensuring compliance with international standards underscores his significant contributions to veterinary science.